1. Home
  2. REVB vs ASTC Comparison

REVB vs ASTC Comparison

Compare REVB & ASTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

HOLD

Current Price

$0.86

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Logo Astrotech Corporation (DE)

ASTC

Astrotech Corporation (DE)

HOLD

Current Price

$3.74

Market Cap

5.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
REVB
ASTC
Founded
2020
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
5.9M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
REVB
ASTC
Price
$0.86
$3.74
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
99.4K
133.0K
Earning Date
11-06-2025
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,312,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.06
52 Week Low
$0.83
$2.47
52 Week High
$60.48
$8.01

Technical Indicators

Market Signals
Indicator
REVB
ASTC
Relative Strength Index (RSI) 36.34 52.50
Support Level $0.93 $3.43
Resistance Level $0.90 $3.91
Average True Range (ATR) 0.07 0.40
MACD -0.01 0.01
Stochastic Oscillator 3.46 43.74

Price Performance

Historical Comparison
REVB
ASTC

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About ASTC Astrotech Corporation (DE)

Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.

Share on Social Networks: